PKM and esophageal squamous cell carcinoma: Consistent with this, high expression of both V-ATPase V1E1 and p-PKM2 was associated with poorer prognosis in ESCC, implicating V-ATPase V1E1 in deregulation of glucose metabolism in the development of ESCC.